BioNxt Solutions Inc. (BNXTF)

Market Cap	36.34M
Revenue (ttm)	31.10K
Net Income (ttm)	-4.80M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,000
Average Volume	5,243
Open	0.3250
Previous Close	0.3016
Day's Range	0.3250 - 0.3250
52-Week Range	0.1116 - 0.4328
Beta	1.61
RSI	41.55
Earnings Date	Apr 22, 2025

About BioNxt Solutions

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was f...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: BNXTF

Financial Performance

In 2023, BioNxt Solutions's revenue was 372,247, an increase of 25.15% compared to the previous year's 297,442. Losses were -7.72 million, -37.60% less than in 2022.

Financial numbers in CAD